ATE308612T1 - Als impfstoff verwendbares attenuiertes influenzavirus - Google Patents
Als impfstoff verwendbares attenuiertes influenzavirusInfo
- Publication number
- ATE308612T1 ATE308612T1 AT00951687T AT00951687T ATE308612T1 AT E308612 T1 ATE308612 T1 AT E308612T1 AT 00951687 T AT00951687 T AT 00951687T AT 00951687 T AT00951687 T AT 00951687T AT E308612 T1 ATE308612 T1 AT E308612T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine
- virus
- influenza virus
- poly
- usable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14614599P | 1999-07-30 | 1999-07-30 | |
GBGB9917981.4A GB9917981D0 (en) | 1999-07-30 | 1999-07-30 | Viral vaccine |
PCT/GB2000/002933 WO2001009291A1 (en) | 1999-07-30 | 2000-07-28 | Attenuated influenza virus useful as vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE308612T1 true ATE308612T1 (de) | 2005-11-15 |
Family
ID=26315811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00951687T ATE308612T1 (de) | 1999-07-30 | 2000-07-28 | Als impfstoff verwendbares attenuiertes influenzavirus |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1200563B1 (de) |
JP (1) | JP2003508086A (de) |
CN (1) | CN1451038A (de) |
AT (1) | ATE308612T1 (de) |
AU (1) | AU6454700A (de) |
CA (1) | CA2380514A1 (de) |
DE (1) | DE60023708D1 (de) |
MX (1) | MXPA02001009A (de) |
WO (1) | WO2001009291A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ555118A (en) * | 2004-11-11 | 2009-09-25 | Solvay Biologicals Bv | Defective influenza virus particles incapable of producing functional polymerase |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
JP2009512449A (ja) * | 2005-10-19 | 2009-03-26 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | イヌにおける呼吸器疾患管理のための材料および方法 |
GB2437799B (en) * | 2006-05-24 | 2008-08-13 | Univ Warwick | Defective interfering virus |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166057A (en) * | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
-
2000
- 2000-07-28 AT AT00951687T patent/ATE308612T1/de not_active IP Right Cessation
- 2000-07-28 CA CA002380514A patent/CA2380514A1/en not_active Abandoned
- 2000-07-28 EP EP00951687A patent/EP1200563B1/de not_active Expired - Lifetime
- 2000-07-28 JP JP2001521986A patent/JP2003508086A/ja not_active Withdrawn
- 2000-07-28 MX MXPA02001009A patent/MXPA02001009A/es unknown
- 2000-07-28 DE DE60023708T patent/DE60023708D1/de not_active Expired - Lifetime
- 2000-07-28 WO PCT/GB2000/002933 patent/WO2001009291A1/en active IP Right Grant
- 2000-07-28 AU AU64547/00A patent/AU6454700A/en not_active Abandoned
- 2000-07-28 CN CN00813421A patent/CN1451038A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1200563A1 (de) | 2002-05-02 |
WO2001009291A1 (en) | 2001-02-08 |
CA2380514A1 (en) | 2001-02-08 |
DE60023708D1 (de) | 2005-12-08 |
MXPA02001009A (es) | 2002-10-31 |
CN1451038A (zh) | 2003-10-22 |
EP1200563B1 (de) | 2005-11-02 |
AU6454700A (en) | 2001-02-19 |
JP2003508086A (ja) | 2003-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Whisnant et al. | Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus | |
Suguitan Jr et al. | The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals | |
BR112012011381B8 (pt) | oligonucleotídeo antisenso antiviral isolado e composição farmacêutica compreendendo o mesmo | |
EA200900681A1 (ru) | Композиция для лечения респираторных синцитиальных вирусов | |
Dowall et al. | Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity | |
DK1218545T3 (da) | Fremgangsmåder til fremstilling af oligonukleotidopløsninger | |
ATE420192T1 (de) | Verfahren zur verringerung der antigenität des adeno-assoziierten virus strukturproteins | |
WO2006083800A3 (en) | Nucleic acid silencing of huntington's disease gene | |
DK0857211T3 (da) | Stærk homolog promoter fra hamster | |
WO2004013280A3 (en) | ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING | |
NO990025D0 (no) | Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA | |
NO20072722L (no) | Preparater og fremgangsmate for a rense nukleinsyrer fra stabiliseringsreagenser | |
ATE368106T1 (de) | Zusammensetzungen und verfahren zur extraktion einer nukleinsäure | |
DE60327471D1 (de) | Verfahren und zusammensetzungen zur reinigung von nukleinsäure aus einer wirtszelle | |
WO2005105829A3 (en) | Caspase-2 inhibitors and their biological applications | |
AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
ATE548454T1 (de) | Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis | |
Lim et al. | Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro | |
Haque et al. | Chromatin and splicing | |
Brenner et al. | A methylation rendezvous: reader meets writers | |
HUP0301869A2 (hu) | DNS-tisztítási eljárások és a tisztított DNS | |
ATE308612T1 (de) | Als impfstoff verwendbares attenuiertes influenzavirus | |
DE60331758D1 (de) | Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung | |
Sarda et al. | Orphan CpG islands as alternative promoters | |
Xu et al. | Novel miniature CRISPR–Cas13 systems from uncultivated microbes effective in degrading SARS-CoV-2 sequences and influenza viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |